Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2016. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3289974011 | Cyclophosphamide therapy (procedure) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3290077012 | Cyclophosphamide therapy | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cyclophosphamide therapy | Is a | Administration of antineoplastic agent | false | Inferred relationship | Existential restriction modifier | ||
| Cyclophosphamide therapy | Is a | Drug therapy | true | Inferred relationship | Existential restriction modifier | ||
| Cyclophosphamide therapy | Has intent | Therapeutic intent | true | Inferred relationship | Existential restriction modifier | 1 | |
| Cyclophosphamide therapy | Method | Administration - action | true | Inferred relationship | Existential restriction modifier | 2 | |
| Cyclophosphamide therapy | Direct substance | Cyclophosphamide | true | Inferred relationship | Existential restriction modifier | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Long-term current use of cyclophosphamide | Associated procedure | True | Cyclophosphamide therapy | Inferred relationship | Existential restriction modifier | 1 |
| Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy regimen | Is a | True | Cyclophosphamide therapy | Inferred relationship | Existential restriction modifier | |
| Rituximab, cyclophosphamide, etoposide, vincristine, prednisone antineoplastic chemotherapy regimen | Is a | True | Cyclophosphamide therapy | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR